3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Classical hematology
1
Conditions
Sarcoma
171
Glioblastoma
72
Gliosarcoma
70
Brain Neoplasms
41
Osteosarcoma
40
Neoplasms
40
Astrocytoma
38
Recurrence
35
Melanoma
33
Oligodendroglioma
32
Gastrointestinal Stromal Tumors
31
Breast Neoplasms
31
Glioma
30
Lymphoma
29
Dendritic Cell Sarcoma, Interdigitating
29
Precursor Cell Lymphoblastic Leukemia-Lymphoma
28
Neoplasm Metastasis
28
Central Nervous System Neoplasms
27
Burkitt Lymphoma
26
Bone Neoplasms
26
Ovarian Neoplasms
25
Colorectal Neoplasms
24
Neuroblastoma
22
Lymphoma, Non-Hodgkin
22
Lymphoma, Large B-Cell, Diffuse
22
Stomach Neoplasms
21
Sarcoma, Ewing
21
Lung Neoplasms
19
Leukemia, Myeloid, Acute
19
Leukemia
19
Interventions
Pregabalin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Pain, Intractable
×
Sarcoma
×
Clear all
NCT00381095
2021-01-20
COPE
Pfizer
Phase 4
Terminated
152 enrolled
14 charts